ピペラシリンナトリウムのグローバル市場2021

• 英文タイトル：Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Report 2021

• レポートコード：QAF27844 • 出版社/出版日：QYResearch / 2021年4月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本市場調査資料では、世界のピペラシリンナトリウム市場について種類別（ピペラシリン、ピペラシリン、タゾバクタム）、用途別（ピペラシリンナトリウム注射、ピペラシリンナトリウム化合物注射）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ピペラシリンナトリウム市場の概要 ・世界の主要地域別ピペラシリンナトリウム市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のピペラシリンナトリウム市場規模2016-2021：種類別（ピペラシリン、ピペラシリン、タゾバクタム） ・世界のピペラシリンナトリウム市場予測2012-2027：種類別（ピペラシリン、ピペラシリン、タゾバクタム） ・世界のピペラシリンナトリウム市場規模2016-2021：用途別（ピペラシリンナトリウム注射、ピペラシリンナトリウム化合物注射） ・世界のピペラシリンナトリウム市場予測2012-2027：用途別（ピペラシリンナトリウム注射、ピペラシリンナトリウム化合物注射） ・ピペラシリンナトリウムのアメリカ市場規模と予測2016-2021 ・ピペラシリンナトリウムのヨーロッパ市場規模と予測2016-2021 ・ピペラシリンナトリウムの中国市場規模と予測2016-2021 ・ピペラシリンナトリウムの日本市場規模と予測2016-2021 ・ピペラシリンナトリウムの東南アジア市場規模と予測2016-2021 ・ピペラシリンナトリウムのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Qilu Pharmaceutical、Pfizer Healthcare、Fresenius Kabi AG、Aurobindo Pharma、Sandoz Inc、NCPC、REYOUNG、Yuhan Corporation、LKPC、Nectar Lifesciences、Sterile India、Suanfarma、Rajasthan Antibiotics） ・ピペラシリンナトリウムの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ピペラシリンナトリウムの市場動向・機会・課題 ・調査の結論

Piperacillin Sodium is the sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity.
The classification of Piperacillin Sodium includes Piperacillin Sodium and Piperacillin and Tazobactam. The proportion of Piperacillin and Tazobactam in 2019 is about 78%, and the proportion is in increasing trend from 2015 to 2020.
Piperacillin Sodium is widely used in Piperacillin Sodium Injection and Piperacillin Sodium Compound Injection. The most proportion of Piperacillin Sodium is used in Piperacillin Sodium Compound Injection and the proportion in 2019 is about 86%.
China is the largest supply country, it account about 47% of global production in 2019, India is the second largest country with 33% of global share.
Asia-Pacific is the largest consumption market, with a market share nearly 84% in 2019. Following Asia-Pacific, Europe is the second largest consumption market with the market share of 12%.
Qilu Pharmaceutical, Pfizer Healthcare, Fresenius Kabi AG, Aurobindo Pharma, Sandoz Inc, NCPC s, etc. are the leaders of the industry.

Market Analysis and Insights: Global Piperacillin Sodium (CAS 59703-84-3) Market
The global Piperacillin Sodium (CAS 59703-84-3) market was valued at US$ 199 in 2020 and will reach US$ 210 million by the end of 2027, growing at a CAGR of 0.9% during 2022-2027.

Global Piperacillin Sodium (CAS 59703-84-3) Scope and Market Size
The global Piperacillin Sodium (CAS 59703-84-3) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Piperacillin Sodium (CAS 59703-84-3) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Piperacillin
Piperacillin and Tazobactam

Segment by Application
Piperacillin Sodium Injection
Piperacillin Sodium Compound Injection

The Piperacillin Sodium (CAS 59703-84-3) market is analysed and market size information is provided by regions (countries). Segment by Application, the Piperacillin Sodium (CAS 59703-84-3) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Qilu Pharmaceutical
Pfizer Healthcare
Fresenius Kabi AG
Aurobindo Pharma
Sandoz Inc
NCPC
REYOUNG
Yuhan Corporation
LKPC
Nectar Lifesciences
Sterile India
Suanfarma
Rajasthan Antibiotics

レポート目次

---

1 Piperacillin Sodium (CAS 59703-84-3) Market Overview
1.1 Piperacillin Sodium (CAS 59703-84-3) Product Scope
1.2 Piperacillin Sodium (CAS 59703-84-3) Segment by Type
1.2.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2016 & 2021 & 2027)
1.2.2 Piperacillin
1.2.3 Piperacillin and Tazobactam
1.3 Piperacillin Sodium (CAS 59703-84-3) Segment by Application
1.3.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Piperacillin Sodium Injection
1.3.3 Piperacillin Sodium Compound Injection
1.4 Piperacillin Sodium (CAS 59703-84-3) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Piperacillin Sodium (CAS 59703-84-3) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Piperacillin Sodium (CAS 59703-84-3) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Piperacillin Sodium (CAS 59703-84-3) Price Trends (2016-2027)

2 Piperacillin Sodium (CAS 59703-84-3) Estimates and Forecasts by Region
2.1 Global Piperacillin Sodium (CAS 59703-84-3) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Piperacillin Sodium (CAS 59703-84-3) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Region (2016-2021)
2.2.2 Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Region (2016-2021)
2.3 Global Piperacillin Sodium (CAS 59703-84-3) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Piperacillin Sodium (CAS 59703-84-3) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Piperacillin Sodium (CAS 59703-84-3) Estimates and Projections (2016-2027)
2.4.2 Europe Piperacillin Sodium (CAS 59703-84-3) Estimates and Projections (2016-2027)
2.4.3 China Piperacillin Sodium (CAS 59703-84-3) Estimates and Projections (2016-2027)
2.4.4 Japan Piperacillin Sodium (CAS 59703-84-3) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Estimates and Projections (2016-2027)
2.4.6 India Piperacillin Sodium (CAS 59703-84-3) Estimates and Projections (2016-2027)
3 Global Piperacillin Sodium (CAS 59703-84-3) Competition Landscape by Players
3.1 Global Top Piperacillin Sodium (CAS 59703-84-3) Players by Sales (2016-2021)
3.2 Global Top Piperacillin Sodium (CAS 59703-84-3) Players by Revenue (2016-2021)
3.3 Global Piperacillin Sodium (CAS 59703-84-3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Piperacillin Sodium (CAS 59703-84-3) as of 2020)
3.4 Global Piperacillin Sodium (CAS 59703-84-3) Average Price by Company (2016-2021)
3.5 Manufacturers Piperacillin Sodium (CAS 59703-84-3) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Piperacillin Sodium (CAS 59703-84-3) Market Size by Type
4.1 Global Piperacillin Sodium (CAS 59703-84-3) Historic Market Review by Type (2016-2021)
4.1.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2016-2021)
4.1.2 Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Type (2016-2021)
4.1.3 Global Piperacillin Sodium (CAS 59703-84-3) Price by Type (2016-2021)
4.2 Global Piperacillin Sodium (CAS 59703-84-3) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Forecast by Type (2022-2027)
4.2.2 Global Piperacillin Sodium (CAS 59703-84-3) Revenue Forecast by Type (2022-2027)
4.2.3 Global Piperacillin Sodium (CAS 59703-84-3) Price Forecast by Type (2022-2027)
5 Global Piperacillin Sodium (CAS 59703-84-3) Market Size by Application
5.1 Global Piperacillin Sodium (CAS 59703-84-3) Historic Market Review by Application (2016-2021)
5.1.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2016-2021)
5.1.2 Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Application (2016-2021)
5.1.3 Global Piperacillin Sodium (CAS 59703-84-3) Price by Application (2016-2021)
5.2 Global Piperacillin Sodium (CAS 59703-84-3) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Piperacillin Sodium (CAS 59703-84-3) Sales Forecast by Application (2022-2027)
5.2.2 Global Piperacillin Sodium (CAS 59703-84-3) Revenue Forecast by Application (2022-2027)
5.2.3 Global Piperacillin Sodium (CAS 59703-84-3) Price Forecast by Application (2022-2027)

6 North America Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures
6.1 North America Piperacillin Sodium (CAS 59703-84-3) Sales by Company
6.1.1 North America Piperacillin Sodium (CAS 59703-84-3) Sales by Company (2016-2021)
6.1.2 North America Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021)
6.2 North America Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type
6.2.1 North America Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2016-2021)
6.2.2 North America Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2022-2027)
6.3 North America Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Application
6.3.1 North America Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Application (2016-2021)
6.3.2 North America Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Application (2022-2027)

7 Europe Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures
7.1 Europe Piperacillin Sodium (CAS 59703-84-3) Sales by Company
7.1.1 Europe Piperacillin Sodium (CAS 59703-84-3) Sales by Company (2016-2021)
7.1.2 Europe Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021)
7.2 Europe Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type
7.2.1 Europe Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2022-2027)
7.3 Europe Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Application
7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)

8 China Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures
8.1 China Piperacillin Sodium (CAS 59703-84-3) Sales by Company
8.1.1 China Piperacillin Sodium (CAS 59703-84-3) Sales by Company (2016-2021)
8.1.2 China Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021)
8.2 China Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type
8.2.1 China Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2016-2021)
8.2.2 China Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2022-2027)
8.3 China Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)

9 Japan Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures
9.1 Japan Piperacillin Sodium (CAS 59703-84-3) Sales by Company
9.1.1 Japan Piperacillin Sodium (CAS 59703-84-3) Sales by Company (2016-2021)
9.1.2 Japan Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021)
9.2 Japan Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type
9.2.1 Japan Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2022-2027)
9.3 Japan Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures
10.1 Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales by Company
10.1.1 Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales by Company (2016-2021)
10.1.2 Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021)
10.2 Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type
10.2.1 Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Piperacillin Sodium (CAS 59703-84-3) Market Facts & Figures
11.1 India Piperacillin Sodium (CAS 59703-84-3) Sales by Company
11.1.1 India Piperacillin Sodium (CAS 59703-84-3) Sales by Company (2016-2021)
11.1.2 India Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021)
11.2 India Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type
11.2.1 India Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2016-2021)
11.2.2 India Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Type (2022-2027)
11.3 India Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Application
11.3.1 India Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Application (2016-2021)
11.3.2 India Piperacillin Sodium (CAS 59703-84-3) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Piperacillin Sodium (CAS 59703-84-3) Business
12.1 Qilu Pharmaceutical
12.1.1 Qilu Pharmaceutical Corporation Information
12.1.2 Qilu Pharmaceutical Business Overview
12.1.3 Qilu Pharmaceutical Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Qilu Pharmaceutical Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.1.5 Qilu Pharmaceutical Recent Development
12.2 Pfizer Healthcare
12.2.1 Pfizer Healthcare Corporation Information
12.2.2 Pfizer Healthcare Business Overview
12.2.3 Pfizer Healthcare Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Healthcare Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.2.5 Pfizer Healthcare Recent Development
12.3 Fresenius Kabi AG
12.3.1 Fresenius Kabi AG Corporation Information
12.3.2 Fresenius Kabi AG Business Overview
12.3.3 Fresenius Kabi AG Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Fresenius Kabi AG Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.3.5 Fresenius Kabi AG Recent Development
12.4 Aurobindo Pharma
12.4.1 Aurobindo Pharma Corporation Information
12.4.2 Aurobindo Pharma Business Overview
12.4.3 Aurobindo Pharma Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Aurobindo Pharma Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.4.5 Aurobindo Pharma Recent Development
12.5 Sandoz Inc
12.5.1 Sandoz Inc Corporation Information
12.5.2 Sandoz Inc Business Overview
12.5.3 Sandoz Inc Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sandoz Inc Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.5.5 Sandoz Inc Recent Development
12.6 NCPC
12.6.1 NCPC Corporation Information
12.6.2 NCPC Business Overview
12.6.3 NCPC Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 NCPC Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.6.5 NCPC Recent Development
12.7 REYOUNG
12.7.1 REYOUNG Corporation Information
12.7.2 REYOUNG Business Overview
12.7.3 REYOUNG Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 REYOUNG Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.7.5 REYOUNG Recent Development
12.8 Yuhan Corporation
12.8.1 Yuhan Corporation Corporation Information
12.8.2 Yuhan Corporation Business Overview
12.8.3 Yuhan Corporation Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Yuhan Corporation Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.8.5 Yuhan Corporation Recent Development
12.9 LKPC
12.9.1 LKPC Corporation Information
12.9.2 LKPC Business Overview
12.9.3 LKPC Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 LKPC Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.9.5 LKPC Recent Development
12.10 Nectar Lifesciences
12.10.1 Nectar Lifesciences Corporation Information
12.10.2 Nectar Lifesciences Business Overview
12.10.3 Nectar Lifesciences Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Nectar Lifesciences Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.10.5 Nectar Lifesciences Recent Development
12.11 Sterile India
12.11.1 Sterile India Corporation Information
12.11.2 Sterile India Business Overview
12.11.3 Sterile India Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sterile India Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.11.5 Sterile India Recent Development
12.12 Suanfarma
12.12.1 Suanfarma Corporation Information
12.12.2 Suanfarma Business Overview
12.12.3 Suanfarma Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Suanfarma Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.12.5 Suanfarma Recent Development
12.13 Rajasthan Antibiotics
12.13.1 Rajasthan Antibiotics Corporation Information
12.13.2 Rajasthan Antibiotics Business Overview
12.13.3 Rajasthan Antibiotics Piperacillin Sodium (CAS 59703-84-3) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Rajasthan Antibiotics Piperacillin Sodium (CAS 59703-84-3) Products Offered
12.13.5 Rajasthan Antibiotics Recent Development

13 Piperacillin Sodium (CAS 59703-84-3) Manufacturing Cost Analysis
13.1 Piperacillin Sodium (CAS 59703-84-3) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Piperacillin Sodium (CAS 59703-84-3)
13.4 Piperacillin Sodium (CAS 59703-84-3) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Piperacillin Sodium (CAS 59703-84-3) Distributors List
14.3 Piperacillin Sodium (CAS 59703-84-3) Customers

15 Market Dynamics
15.1 Piperacillin Sodium (CAS 59703-84-3) Market Trends
15.2 Piperacillin Sodium (CAS 59703-84-3) Drivers
15.3 Piperacillin Sodium (CAS 59703-84-3) Market Challenges
15.4 Piperacillin Sodium (CAS 59703-84-3) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Piperacillin Sodium (CAS 59703-84-3) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Piperacillin Sodium (CAS 59703-84-3) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Piperacillin Sodium (CAS 59703-84-3) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Region (2016-2021)
Table 5. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Region (2016-2021)
Table 6. Global Piperacillin Sodium (CAS 59703-84-3) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share by Region (2016-2021)
Table 8. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Piperacillin Sodium (CAS 59703-84-3) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) of Key Companies (2016-2021)
Table 13. Global Piperacillin Sodium (CAS 59703-84-3) Sales Share by Company (2016-2021)
Table 14. Global Piperacillin Sodium (CAS 59703-84-3) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share by Company (2016-2021)
Table 16. Global Piperacillin Sodium (CAS 59703-84-3) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Piperacillin Sodium (CAS 59703-84-3) as of 2020)
Table 17. Global Piperacillin Sodium (CAS 59703-84-3) Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Piperacillin Sodium (CAS 59703-84-3) Manufacturing Sites and Area Served
Table 19. Manufacturers Piperacillin Sodium (CAS 59703-84-3) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Type (2016-2021)
Table 22. Global Piperacillin Sodium (CAS 59703-84-3) Sales Share by Type (2016-2021)
Table 23. Global Piperacillin Sodium (CAS 59703-84-3) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Piperacillin Sodium (CAS 59703-84-3) Price (USD/Kg) by Type (2016-2021)
Table 25. Global Piperacillin Sodium (CAS 59703-84-3) Sales Share by Type (2022-2027)
Table 26. Global Piperacillin Sodium (CAS 59703-84-3) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share by Type (2022-2027)
Table 28. Global Piperacillin Sodium (CAS 59703-84-3) Price (USD/Kg) by Type (2022-2027)
Table 29. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Application (2016-2021)
Table 30. Global Piperacillin Sodium (CAS 59703-84-3) Sales Share by Application (2016-2021)
Table 31. Global Piperacillin Sodium (CAS 59703-84-3) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Piperacillin Sodium (CAS 59703-84-3) Price (USD/Kg) by Application (2016-2021)
Table 33. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Application (2022-2027)
Table 34. Global Piperacillin Sodium (CAS 59703-84-3) Sales Share by Application (2022-2027)
Table 35. Global Piperacillin Sodium (CAS 59703-84-3) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share by Application (2022-2027)
Table 37. Global Piperacillin Sodium (CAS 59703-84-3) Price (USD/Kg) by Application (2022-2027)
Table 38. North America Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Company (2016-2021)
Table 39. North America Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Company (2016-2021)
Table 40. North America Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Company (2016-2021)
Table 42. North America Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2016-2021) & (MT)
Table 43. North America Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2016-2021)
Table 44. North America Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2022-2027) & (MT)
Table 45. North America Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2022-2027)
Table 46. North America Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2016-2021) & (MT)
Table 47. North America Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2016-2021)
Table 48. North America Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2022-2027) & (MT)
Table 49. North America Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2022-2027)
Table 50. Europe Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Company (2016-2021)
Table 51. Europe Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Company (2016-2021)
Table 52. Europe Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Company (2016-2021)
Table 54. Europe Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2016-2021) & (MT)
Table 55. Europe Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2016-2021)
Table 56. Europe Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2022-2027) & (MT)
Table 57. Europe Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2022-2027)
Table 58. Europe Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2016-2021) & (MT)
Table 59. Europe Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2016-2021)
Table 60. Europe Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2022-2027) & (MT)
Table 61. Europe Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2022-2027)
Table 62. China Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Company (2016-2021)
Table 63. China Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Company (2016-2021)
Table 64. China Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Company (2016-2021)
Table 66. China Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2016-2021) & (MT)
Table 67. China Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2016-2021)
Table 68. China Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2022-2027) & (MT)
Table 69. China Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2022-2027)
Table 70. China Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2016-2021) & (MT)
Table 71. China Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2016-2021)
Table 72. China Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2022-2027) & (MT)
Table 73. China Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2022-2027)
Table 74. Japan Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Company (2016-2021)
Table 75. Japan Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Company (2016-2021)
Table 76. Japan Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Company (2016-2021)
Table 78. Japan Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2016-2021) & (MT)
Table 79. Japan Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2016-2021)
Table 80. Japan Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2022-2027) & (MT)
Table 81. Japan Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2022-2027)
Table 82. Japan Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2016-2021) & (MT)
Table 83. Japan Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2016-2021)
Table 84. Japan Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2022-2027) & (MT)
Table 85. Japan Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2022-2027)
Table 98. India Piperacillin Sodium (CAS 59703-84-3) Sales (MT) by Company (2016-2021)
Table 99. India Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Company (2016-2021)
Table 100. India Piperacillin Sodium (CAS 59703-84-3) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Company (2016-2021)
Table 102. India Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2016-2021) & (MT)
Table 103. India Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2016-2021)
Table 104. India Piperacillin Sodium (CAS 59703-84-3) Sales by Type (2022-2027) & (MT)
Table 105. India Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type (2022-2027)
Table 106. India Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2016-2021) & (MT)
Table 107. India Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2016-2021)
Table 108. India Piperacillin Sodium (CAS 59703-84-3) Sales by Application (2022-2027) & (MT)
Table 109. India Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application (2022-2027)
Table 110. Qilu Pharmaceutical Corporation Information
Table 111. Qilu Pharmaceutical Description and Business Overview
Table 112. Qilu Pharmaceutical Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Qilu Pharmaceutical Piperacillin Sodium (CAS 59703-84-3) Product
Table 114. Qilu Pharmaceutical Recent Development
Table 115. Pfizer Healthcare Corporation Information
Table 116. Pfizer Healthcare Description and Business Overview
Table 117. Pfizer Healthcare Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Pfizer Healthcare Piperacillin Sodium (CAS 59703-84-3) Product
Table 119. Pfizer Healthcare Recent Development
Table 120. Fresenius Kabi AG Corporation Information
Table 121. Fresenius Kabi AG Description and Business Overview
Table 122. Fresenius Kabi AG Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Fresenius Kabi AG Piperacillin Sodium (CAS 59703-84-3) Product
Table 124. Fresenius Kabi AG Recent Development
Table 125. Aurobindo Pharma Corporation Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Aurobindo Pharma Piperacillin Sodium (CAS 59703-84-3) Product
Table 129. Aurobindo Pharma Recent Development
Table 130. Sandoz Inc Corporation Information
Table 131. Sandoz Inc Description and Business Overview
Table 132. Sandoz Inc Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Sandoz Inc Piperacillin Sodium (CAS 59703-84-3) Product
Table 134. Sandoz Inc Recent Development
Table 135. NCPC Corporation Information
Table 136. NCPC Description and Business Overview
Table 137. NCPC Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. NCPC Piperacillin Sodium (CAS 59703-84-3) Product
Table 139. NCPC Recent Development
Table 140. REYOUNG Corporation Information
Table 141. REYOUNG Description and Business Overview
Table 142. REYOUNG Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. REYOUNG Piperacillin Sodium (CAS 59703-84-3) Product
Table 144. REYOUNG Recent Development
Table 145. Yuhan Corporation Corporation Information
Table 146. Yuhan Corporation Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Yuhan Corporation Description and Business Overview
Table 148. Yuhan Corporation Piperacillin Sodium (CAS 59703-84-3) Product
Table 149. Yuhan Corporation Recent Development
Table 150. LKPC Corporation Information
Table 151. LKPC Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. LKPC Description and Business Overview
Table 153. LKPC Piperacillin Sodium (CAS 59703-84-3) Product
Table 154. LKPC Recent Development
Table 155. Nectar Lifesciences Corporation Information
Table 156. Nectar Lifesciences Description and Business Overview
Table 157. Nectar Lifesciences Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Nectar Lifesciences Piperacillin Sodium (CAS 59703-84-3) Product
Table 159. Nectar Lifesciences Recent Development
Table 160. Sterile India Corporation Information
Table 161. Sterile India Description and Business Overview
Table 162. Sterile India Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. Sterile India Piperacillin Sodium (CAS 59703-84-3) Product
Table 164. Sterile India Recent Development
Table 165. Suanfarma Corporation Information
Table 166. Suanfarma Description and Business Overview
Table 167. Suanfarma Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. Suanfarma Piperacillin Sodium (CAS 59703-84-3) Product
Table 169. Suanfarma Recent Development
Table 170. Rajasthan Antibiotics Corporation Information
Table 171. Rajasthan Antibiotics Description and Business Overview
Table 172. Rajasthan Antibiotics Piperacillin Sodium (CAS 59703-84-3) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 173. Rajasthan Antibiotics Piperacillin Sodium (CAS 59703-84-3) Product
Table 174. Rajasthan Antibiotics Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Piperacillin Sodium (CAS 59703-84-3) Distributors List
Table 178. Piperacillin Sodium (CAS 59703-84-3) Customers List
Table 179. Piperacillin Sodium (CAS 59703-84-3) Market Trends
Table 180. Piperacillin Sodium (CAS 59703-84-3) Market Drivers
Table 181. Piperacillin Sodium (CAS 59703-84-3) Market Challenges
Table 182. Piperacillin Sodium (CAS 59703-84-3) Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Piperacillin Sodium (CAS 59703-84-3) Product Picture
Figure 2. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application in 2021 & 2027
Figure 6. Piperacillin Sodium Injection Examples
Figure 7. Piperacillin Sodium Compound Injection Examples
Figure 8. Global Piperacillin Sodium (CAS 59703-84-3) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Piperacillin Sodium (CAS 59703-84-3) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Piperacillin Sodium (CAS 59703-84-3) Sales (MT) Growth Rate (2016-2027)
Figure 11. Global Piperacillin Sodium (CAS 59703-84-3) Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 12. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Piperacillin Sodium (CAS 59703-84-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Piperacillin Sodium (CAS 59703-84-3) Sales (MT) Growth Rate (2016-2027)
Figure 16. Europe Piperacillin Sodium (CAS 59703-84-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Piperacillin Sodium (CAS 59703-84-3) Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Piperacillin Sodium (CAS 59703-84-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Piperacillin Sodium (CAS 59703-84-3) Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Piperacillin Sodium (CAS 59703-84-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Piperacillin Sodium (CAS 59703-84-3) Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Piperacillin Sodium (CAS 59703-84-3) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Piperacillin Sodium (CAS 59703-84-3) Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Piperacillin Sodium (CAS 59703-84-3) Players Market Share by Revenue in Piperacillin Sodium (CAS 59703-84-3): 2016 & 2020
Figure 27. Piperacillin Sodium (CAS 59703-84-3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share by Type (2016-2021)
Figure 29. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Share by Application (2016-2021)
Figure 31. Global Piperacillin Sodium (CAS 59703-84-3) Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type in 2020
Figure 33. North America Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application in 2020
Figure 34. Europe Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type in 2020
Figure 35. Europe Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application in 2020
Figure 36. China Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type in 2020
Figure 37. China Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application in 2020
Figure 38. Japan Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type in 2020
Figure 39. Japan Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application in 2020
Figure 40. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type in 2020
Figure 41. Southeast Asia Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application in 2020
Figure 42. India Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Type in 2020
Figure 43. India Piperacillin Sodium (CAS 59703-84-3) Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Piperacillin Sodium (CAS 59703-84-3)
Figure 46. Manufacturing Process Analysis of Piperacillin Sodium (CAS 59703-84-3)
Figure 47. Piperacillin Sodium (CAS 59703-84-3) Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

---